Back to search
FDAFDA · Food and drugs·Recall number F-0721-2022

Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY

Published February 16, 2022 · Recall initiated: October 6, 2021

Summary

FDA records food Class II recall F-0721-2022, published February 16, 2022 and initiated October 6, 2021. Recalling firm: ULTRAtab Laboratories, Inc.; Status: Terminated; Reported quantity: 4,250,842 tablets; Lot: Product Codes: M943 M943L Bulk Lots: 16K038, 18B075. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ULTRAtab Laboratories, Inc.
Distributor
Bulk product was distributed to 2 distributors (NY, FL) who may have repackaged the product and further distributed finished product.
Lot
Product Codes: M943 M943L Bulk Lots: 16K038, 18B075
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY recalled?

Yes. FDA published recall F-0721-2022 on February 16, 2022. Reported hazard: cGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter